NEW YORK(GenomeWeb) – Protein reagent firm Anatrace has completed its acquisition of Microlytic, which specializes in tools for the structural biology market.

In particular, Microlytic offers products intended to accelerate workflows and improve output quality in soluble protein crystallization.

Anatrace specializes in development and production of high-purity detergents and synthetic lipids for use in membrane protein work. The company is owned by StoneCalibre, a Century City, Calif.-based investment fund.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.

Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.